| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.63B | -0.8% |
| Cost of Revenue | $1.46B | -5.8% |
| Gross Profit | $165.6M | +87.8% |
| R&D Expense | $5.0M | -16.7% |
| SG&A Expense | $92.3M | +21.9% |
| Operating Income | $39.5M | +160.5% |
| Pre-tax Income | -$49.2M | +62.9% |
| Income Tax | -$8.9M | +72.4% |
| Net Income | -$38.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.2M | +65.3% |
| Accounts Receivable | $214.0M | +8.4% |
| Inventory | $208.0M | +0.3% |
| Current Assets | $601.0M | +4.5% |
| Total Assets | $2.13B | -2.4% |
| Current Liabilities | $400.2M | +6.5% |
| Long-term Debt | $706.4M | -6.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $203.6M | +49.4% |
| Investing Cash Flow | -$107.9M | +15.2% |
| Financing Cash Flow | -$42.5M | +51.1% |
| +62.0% |
| EPS (Basic) | -$0.59 | +62.4% |
| EPS (Diluted) | -$0.59 | +62.4% |
| Stockholders' Equity |
| $713.9M |
| -4.4% |